Nevro (NVRO) Tops Q2 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Nevro (NVRO) Tops Q2 EPS by 12c

Nevro Reports Second Quarter 2015 Financial Results

August 6, 2015 4:02 PM EDT

MENLO PARK, Calif., Aug. 6, 2015 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the three and six months ended June 30, 2015.

Recent Accomplishments & Highlights:

Achieved revenue of $11.4 million in the second quarter of 2015, an increase of 52% as reported and 81% on a constant currency basis over the same period of the prior year Received FDA approval for HF10 Spinal Cord Stimulation (SCS) therapy with superiority labeling and... More